Neurology Central

First blood test for concussion assessment wins FDA approval

The FDA has approved the marketing of a novel blood test to assess mild traumatic brain injury (mTBI) in adults, potentially leading to a reduction in the number of unnecessary CT scans.

A more efficient diagnostic tool?

Currently, the majority of patients with suspected mTBI are assessed using the 15-point Glasgow Coma scale, followed by CT scanning to detect intracranial brain lesions that may require treatment.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.